SCHEMBL2363758

SCHEMBL2363758

CCO[Si](CCC1CCC2OC2C1)(OCC)OCC.[SiH4]

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20478203 0.98 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL23061486 0.98 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL14715756 0.98 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL14715755 0.98 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL48916 0.98 PTGS1 (0.32) PTGS1PTGS2
Cyclohexane SCHEMBL19895178 0.94 PTGS1 (0.30) PTGS1PTGS2
SCHEMBL18040471 0.94 PTGS1 (0.30) PTGS1PTGS2
SCHEMBL6755355 0.92 PTGS1 (0.32) PTGS1PTGS2
SCHEMBL188169 0.92 PTGS1 (0.30) PTGS1PTGS2
SCHEMBL9769813 0.91 PPM1B (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023074161-A1 RUBBER COMPOSITION 住友化学株式会社 2023-05-04 WO disclosed
WO-2021111814-A1 FILM ROLL AND PRODUCTION METHOD FOR SAME コニカミノルタ株式会社 2021-06-10 WO disclosed
CN-108193202-A A kind of environment-friendly type metal surface finishing agent and its application 南京科润工业介质股份有限公司 2018-06-22 CN disclosed
US-8916624-B2 Dental compositions crosslinkable/polymerizable by cationic process BLUESTAR SILICONES FRANCE SAS (FR) 2014-12-23 US disclosed
US-20110189632-A1 DENTAL COMPOSITIONS CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS BLUESTAR SILICONES FRANCE (FR) 2011-08-04 US disclosed
US-7740482-B2 Stable cationically crosslinkable/polymerizable dental composition with a high filler content BLUESTAR SILICONES FRANCE (FR) 2010-06-22 US disclosed
EP-1745083-B1 HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION BLUESTAR SILICONES FRANCE (FR) 2009-12-16 EP disclosed
EP-2043588-B1 DENTAL COMPOSITION CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS BLUESTAR SILICONES FRANCE (FR) 2009-11-18 EP disclosed
EP-2043588-A2 DENTAL COMPOSITION CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS Bluestar Silicones France (FR) 2009-04-08 EP disclosed
US-20080287562-A1 Stable cationically crosslinkable/polymerizable dental composition with a high filler content RHODIA CHIMIE (FR) 2008-11-20 US disclosed
WO-2008009718-A2 DENTAL COMPOSITION CROSSLINKABLE/POLYMERIZABLE BY CATIONIC PROCESS BLUESTAR SILICONES FRANCE (FR) 2008-01-24 WO disclosed
EP-1745083-A1 HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION Rhodia Chimie (FR) 2007-01-24 EP disclosed
WO-2005121200-A1 HIGHLY-CHARGED STABLE DENTAL COMPOSITION WHICH MAY BE CROSS-LINKED/POLYMERISED BY CATIONIC REACTION RHODIA CHIMIE (FR) 2005-12-22 WO disclosed
US-20050261390-A1 Stable cationically crosslinkable/polymerizable dental composition with a high filler content RHODIA CHIMIE (FR) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287562-A1 Stable cationically crosslinkable/polymerizable dental composition with a high filler content RFC1, RFC2, HNRNPC PTGS1 1535/4885PTGS2 1393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.